Work

Hyaluronan and its metabolizing enzymes in melanocytic tumors and diffusely infiltrating astrocytomas

Year: 2019
Type: dissertation
Study design: Observational Study
Abstract: Hyaluronan is an abundant glycosaminoglycan in the extracellular space of many human tissues.It is produced by three hyaluronan synthases (HAS1-3) in the inner leaf of the plasma membrane and catabolized by hyaluronidases (HYALs).Hyaluronan and its metabolizing enzymes participate in many essential processes such as inflammation, wound healing and embryogenesis.Thus, alterations in hyaluronan metabolism have become an interesting topic in cancer research.Hyaluronan concentrations often change in malignant tumors compared to benign tissues.The purpose of this thesis was to investigate hyaluronan metabolism in cutaneous melanocytic tumors and in diffusely infiltrating astrocytomas of the central nervous system.It is reported that hyaluronan content is low in cutaneous melanomas compared to benign nevi.However, the mechanisms underlying this finding have not been investigated previously.In this thesis, increased staining of hyaluronan and immunostaining of HAS2 were seen in in situ melanomas compared to benign melanocytic lesions.Interestingly, declined expression of HAS1 and HAS2 and a subsequent decrease in hyaluronan content were observed in melanoma lesions.Dysplastic nevi, in situ melanomas, invasive melanomas and lymph node metastasis of melanoma displayed increased expression of HYAL2 compared to benign nevi.In melanomas, decreased HAS2 immunostaining was associated with several adverse histopathological findings including increased mitotic rate, nodular subtype and reduced number of tumor-infiltrating lymphocytes.Furthermore, decreased HAS1 and HAS2 immunostainings were associated with shorter survival and recurrence-free times of patients.Diffusely infiltrating astrocytomas are malignant glial cell tumors which include the aggressive grade IV glioblastomas.All astrocytomas demonstrated high hyaluronan content and expression of HAS1, HAS2 and HYAL2 were elevated in the high grade astrocytomas.High level immunopositivity of HAS2 and HYAL2 was associated with increased proliferation of tumor cells, while reduced expression of HAS2 correlated with an increased amount of positive prognostic marker IDH1 mutations in tumors.High HAS2 staining was associated with shorter overall survival time of patients.This thesis provides new information on hyaluronan metabolism in two aggressive tumor types.In cutaneous melanoma, hyaluronan content was low due to decreased HAS expression and this correlates with poor prognosis, while in diffusely infiltrating astrocytomas, hyaluronan metabolism shows a different pattern.In astrocytomas, increased HAS2 immunostaining correlated with poor prognosis.Thus, hyaluronan and its metabolizing enzymes are involved in the regulation of cancer progression.
Language: English
Subfield: Cell Biology
Open Access status: green
OpenAlex ID: W3174282588
Cites: 303
Cited by:
Related to: 10